The estimated Net Worth of Michael Sardano is at least $607 Thousand dollars as of 28 August 2023. Mr Sardano owns over 1,000 units of Sensus Healthcare Inc stock worth over $345,591 and over the last 7 years he sold SRTS stock worth over $0. In addition, he makes $261,072 as VP and Gen. Counsel & Corp. Sec. at Sensus Healthcare Inc.
Mr has made over 4 trades of the Sensus Healthcare Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 1,000 units of SRTS stock worth $2,990 on 28 August 2023.
The largest trade he's ever made was exercising 5,000 units of Sensus Healthcare Inc stock on 13 September 2022 worth over $27,750. On average, Mr trades about 615 units every 27 days since 2018. As of 28 August 2023 he still owns at least 58,774 units of Sensus Healthcare Inc stock.
You can see the complete history of Mr Sardano stock trades at the bottom of the page.
Michael J. Sardano is the VP, Gen. Counsel & Corp. Sec. at Sensus Healthcare Inc.
As the VP and Gen. Counsel & Corp. Sec. of Sensus Healthcare Inc, the total compensation of Mr Sardano at Sensus Healthcare Inc is $261,072. There are 4 executives at Sensus Healthcare Inc getting paid more, with Stephen Cohen having the highest compensation of $521,260.
Mr Sardano is 33, he's been the VP and Gen. Counsel & Corp. Sec. of Sensus Healthcare Inc since . There are 15 older and 1 younger executives at Sensus Healthcare Inc. The oldest executive at Sensus Healthcare Inc is John Heinrich, 73, who is the Non-Executive Independent Director.
Michael's mailing address filed with the SEC is 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON, FL, 33487.
Over the last 8 years, insiders at Sensus Healthcare Inc have traded over $8,288,024 worth of Sensus Healthcare Inc stock and bought 88,000 units worth $292,820 . The most active insiders traders include Joseph C Sardano, Stephen Brad Cohen, and Anthony Benedict Petrelli. On average, Sensus Healthcare Inc executives and independent directors trade stock every 29 days with the average trade being worth of $58,482. The most recent stock trade was executed by John Heinrich on 17 May 2024, trading 20,000 units of SRTS stock currently worth $123,400.
sensus healthcare, inc. is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancer and keloids. sensus uses a proprietary low energy x-ray radiation technology known as superficial radiation therapy (srt), which is a result of over a decade of dedicated research and development activities. sensus has successfully incorporated the srt therapy into its portfolio of treatment devices: srt-100™ and srt-100 vision™. srt technology effectively and safely treats oncological and non-oncological skin conditions. for more information, visit http://www.sensushealthcare.com.
Sensus Healthcare Inc executives and other stock owners filed with the SEC include: